Mar 17, 2020
Is there potential for using antibodies generated by people who have recovered from COVID-19 to prevent infection and treat those who are sick? Dr. Josh Sharfstein talks to Arturo Casadevall, chair of Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health, about a landmark 1934 case where antibodies helped stopped a measles outbreak.
More information: jhsph.edu/covid-19